Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;51(1):267-270.
doi: 10.1007/s12029-019-00239-4.

Evaluation of the Methylation of MIR129-2 Gene in Gastric Cancer

Nazila Alizadeh  1 , Milad Asadi  1 , Dariush Shanehbandi  1 , Venus Zafari  2 , Navid Shomali  3 , Touraj Asvadi  4 , Bita Sepehri  5
Affiliations

Evaluation of the Methylation of MIR129-2 Gene in Gastric Cancer

Nazila Alizadeh et al. J Gastrointest Cancer. 2020 Mar.

Abstract

Background: Genetic and epigenetic changes have strong role in the development of gastric cancer. The mutation of the MIR129-2 gene is one of the major causes in many cancers, especially gastric cancer. The aim of this study was to investigate the methylation changes of the MIR129-2 gene in tumor and normal tissue of patients with gastric cancer.

Method: In this study, 50 gastric cancer patients with Iranian Azari ethnic origin without any familial relations were included. Genomic DNAs was extracted from the tumoral and normal tissues. Then the promotor regions of the MIR129-2 gene were analyzed by methylation-specific PCR (MSP) to evaluate the presence or absence of methylated CpG sites.

Results: There was a statistically significant difference in methylation level of MIR129-2 gene between tumoral and normal tissues. It was observed that 84 out of 100 CpG cites were methylated in tumoral tissues in compression to 13 out of 100 CpG cites in normal tissues.

Conclusion: MIR129-2 gene was hypermethylated in tumoral tissues, suggesting that methylation is involved in the development of gastric cancer.

Keywords: CpG site; Gastric cancer; MIR129-2 gene.

PubMed Disclaimer

References

    1. Biochem Biophys Res Commun. 2010 Apr 16;394(4):1047-52 - PubMed
    1. Adv Exp Med Biol. 2013;774:1-20 - PubMed
    1. Biomed Pharmacother. 2017 Dec;96:238-245 - PubMed
    1. PLoS One. 2012;7(4):e35800 - PubMed
    1. Int J Cancer. 2009 Dec 1;125(11):2737-43 - PubMed

LinkOut - more resources